In vitro volatile exometabolome signature of clear cell renal cell carcinoma

被引:0
|
作者
Amaro, F. S. [1 ]
Pinto, J. [1 ]
Rocha, S. [1 ]
Araujo, A. M. [1 ]
Goncalves, V. M. [2 ]
Jeronimo, C. [2 ,3 ,4 ]
Henrique, R. [3 ,4 ,5 ]
Bastos, M. D. L. [1 ]
Carvalho, M. [1 ,6 ]
Pinho, P. G. D. [1 ]
机构
[1] Univ Porto, Dept Biol Sci, Toxicol Lab, UCIBIO REQUIMTE,Fac Pharm, Porto, Portugal
[2] IPO Porto Res Ctr, Canc Biol & Epigenet Grp, Porto, Portugal
[3] Univ Porto, Inst Biomed Sci Abel Salazar ICBAS, Dept Pathol & Mol Immunol, Porto, Portugal
[4] IPO Porto Res Ctr, Porto Comprehens Canc Ctr, Porto, Portugal
[5] Portuguese Oncol Inst Porto, Dept Pathol, Porto, Portugal
[6] UFP Energy, Environm & Hlth Res Unit, Porto, Portugal
关键词
D O I
暂无
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
P04-45
引用
收藏
页码:S107 / S107
页数:1
相关论文
共 50 条
  • [31] Association of CXCL13 and Immune Cell Infiltration Signature in Clear Cell Renal Cell Carcinoma
    Jiao, Fangdong
    Sun, Hao
    Yang, Qingya
    Sun, Hui
    Wang, Zehua
    Liu, Ming
    Chen, Jun
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2020, 17 (11): : 1610 - 1624
  • [32] Clear Cell Papillary Renal Cell Carcinoma (CCPAP): A Distinct Entity or a Variant of Clear Cell Renal Cell Carcinoma?
    Rohan, S. M.
    Dudas, M. E.
    Gopalan, A.
    Fine, S. W.
    Reuter, V. E.
    Tickoo, S. K.
    LABORATORY INVESTIGATION, 2009, 89 : 191A - 191A
  • [33] Clear Cell Papillary Renal Cell Carcinoma (CCPAP): A Distinct Entity or a Variant of Clear Cell Renal Cell Carcinoma?
    Rohan, S. M.
    Dudas, M. E.
    Gopalan, A.
    Fine, S. W.
    Reuter, V. E.
    Tickoo, S. K.
    MODERN PATHOLOGY, 2009, 22 : 191A - 191A
  • [34] The unique genomic landscape and prognostic mutational signature of Chinese clear cell renal cell carcinoma
    Xu, Wenhao
    Anwaier, Aihetaimujiang
    Liu, Wangrui
    Tian, Xi
    Su, Jiaqi
    Shi, Guohai
    Qu, Yuanyuan
    Zhang, Hailiang
    Ye, Dingwei
    JOURNAL OF THE NATIONAL CANCER CENTER, 2022, 2 (03): : 162 - 170
  • [35] Prognostic Gene Expression-Based Signature in Clear-Cell Renal Cell Carcinoma
    Roldan, Fiorella L.
    Izquierdo, Laura
    Ingelmo-Torres, Mercedes
    Lozano, Juan Jose
    Carrasco, Raquel
    Cunado, Alexandra
    Reig, Oscar
    Mengual, Lourdes
    Alcaraz, Antonio
    CANCERS, 2022, 14 (15)
  • [36] A MUCINs expression signature impacts overall survival in patients with clear cell renal cell carcinoma
    Meng, Hui
    Jiang, Xuewen
    Huang, Huangwei
    Shen, Neng
    Guo, Changsheng
    Yu, Chunxiao
    Yin, Gang
    Wang, Yu
    CANCER MEDICINE, 2021, 10 (17): : 5823 - 5838
  • [37] Identification of a 4-microRNA Signature for Clear Cell Renal Cell Carcinoma Metastasis and Prognosis
    Wu, Xiwei
    Weng, Lihong
    Li, Xuejun
    Guo, Chao
    Pal, Sumanta K.
    Jin, Jennifer M.
    Li, Yuping
    Nelson, Rebecca A.
    Mu, Bing
    Onami, Susan H.
    Wu, Jeffrey J.
    Ruel, Nora H.
    Wilczynski, Sharon P.
    Gao, Hanlin
    Covarrubias, Maricela
    Figlin, Robert A.
    Weiss, Lawrence M.
    Wu, Huiqing
    PLOS ONE, 2012, 7 (05):
  • [38] Construction of cuproptosis signature based on bioinformatics and experimental validation in clear cell renal cell carcinoma
    Xi Tian
    Shuxuan Zhu
    Wangrui Liu
    Xinrui Wu
    Gaomeng Wei
    Ji Zhang
    Aihetaimujiang Anwaier
    Cong chen
    Shiqi Ye
    Xiangxian Che
    Wenhao Xu
    Yuanyuan Qu
    Hailiang Zhang
    Dingwei Ye
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 17451 - 17466
  • [39] A Metastasis-Related lncRNA Signature Correlates With the Prognosis in Clear Cell Renal Cell Carcinoma
    Dou, Qian
    Gao, Shun
    Gan, Hua
    Kang, Zhao
    Zhang, Han
    Yang, Yichun
    Tong, Hang
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [40] Development and Validation of a Necroptosis-Related Prognostic Signature for Clear Cell Renal Cell Carcinoma
    Tao, Y. M.
    Ruan, H.
    Dang, W. P.
    Xu, Xinxin
    Li, Y. S.
    INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2022, 84 : 156 - 167